Background: In our swine model of obliterative bronchiolitis preventing obl
iteration by the standard immunosuppression with cyclosporine, methylpredni
solone, and azathioprine was not successful. The purpose of this study was
to test the ability of a new immunosuppressive regimen to prevent alloimmun
e reaction and obliteration of the allografts. This regimen includes the no
vel macrolide SDZ RAD, i.e., 40-O-(2hydroxyethyl)-rapamycin.
Methods: Donor lung allografts of 1 cm(3) were implanted sub-cutaneously in
to 11 random-bred non-related domestic pigs receiving daily oral cyclospori
ne (10 mg/kg) and methylprednisolone (20 mg). In addition, the animals rece
ived either oral azathioprine (2 mg/kg) (Group 1) or oral SDZ RAD (1.5 mg/k
g) (Group 2). Histologic alterations were graded from 0 to 3 based on repea
tedly removed implants during a follow-up period of 3 months.
Results: Total epithelial destruction and permanent luminal obliteration oc
curred within 37 days in Group 1. After an initial grade of 2.3 +/- 0.3 des
truction, epithelial recovery was evident in Group 2 (P < 0.01), and the br
onchi stayed patent. Cartilaginous destruction was milder in Group 2 (P < 0
.05) than in Group 1, but chondrocytic proliferation was more intense (P <
0.05). Alveolar tissue and native structures of the bronchial wall were des
troyed in Group 1, but preserved in Group 2 with total recovery after a mil
d-grade initial necrosis.
Conclusions: Unlike the standard triple therapy, SDZ RAD combined with cycl
osporine and methylprednisolone preserves the pulmonary allografts and prev
ents epithelial destruction and subsequent luminal obliteration. This sugge
sts that this regimen might efficiently suppress obliterative bronchiolitis
and improve long-term results in lung transplant recipients.